Download our whitepaper,
"Navigating the Complex Landscape of Obesity Clinical Trials: Diagnosis Criteria, Pivotal Endpoints and Enhanced Protocols"
What's Inside:
- Key FDA-Approved Pivotal Endpoints for Obesity Clinical Trials.
- Optimizing Recruitment with Adaptive Trial Designs for Obesity.
- Comprehensive Analysis of FDA-Approved Obesity Drugs.
- How Diagnostic Criteria for Obesity Have Evolved and Impact Research.
- Overcoming Common Pitfalls in Obesity Clinical Trials.
- And additional insights to drive your trial's success.
Access your complimentary whitepaper today:
Obesity
Obesity is a chronic complex disease defined by excessive adiposity that can impair health. It is in most cases a multifactorial disease due to obesogenic environments, psycho-social factors and genetic variants.
Characterized by excessive adiposity that can impair health, obesity is influenced by a complex interplay of genetic, biological, psychological, and environmental factors. This complexity necessitates a multidisciplinary approach to prevention, management, and treatment.
iNGENū’s team of researchers and clinicians is dedicated to advancing obesity research. Through innovative trial designs and a patient-centered approach, we work to accelerate the development of new treatments that could offer improved options and outcomes for those affected by obesity.
3x
rates of obesity have increased in the USA since 1970
42%
of adults in the USA are obese
25%
of people with obesity may have an undiagnosed metabolic disease
Our clinical team has over
120
years of combined clinical trial experience